by Scott Larrivee | Jan 10, 2025 | News
High-volume, breakthrough radioisotope production platform to enable innovation in life sciences and industrial applications VALENCIA, Calif. – January 10, 2025 – Nusano, a privately held physics company transforming the production of radioisotopes utilized in...
by Scott Larrivee | Dec 9, 2024 | News
VALENCIA, Calif. and SYDNEY, Australia – Dec. 9, 2024 – Nusano, a physics company transforming the production of radioisotopes, and GlyTherix Ltd (GlyTherix) an Australian targeted radiotherapy company specializing in developing antibody radiopharmaceuticals for solid...
by Scott Larrivee | Oct 17, 2024 | News
Image above: Starget Pharma, stargetpharma.com VALENCIA, Calif. and TEL AVIV, Israel – Oct. 17, 2024 – Nusano, a physics company transforming the production of radioisotopes, and Starget Pharma, a clinical-stage biotechnology company developing precision peptide...
by Scott Larrivee | Oct 1, 2024 | News
Funding supports development and commercialization of broad array of isotopes for medical, commercial and industrial uses VALENCIA, Calif. – Oct. 1, 2024 – Nusano, Inc., a physics company transforming the production of radioisotopes, today announced a Series C...
by Scott Larrivee | Jul 10, 2024 | News
VALENCIA, Calif. and BOCA RATON, Fla. – July 10, 2024 – Nusano Inc. (Nusano), a physics company transforming the production of medical radioisotopes, and PharmaLogic Holdings Corp. (PharmaLogic), a leading radiopharmaceutical contract development and manufacturing...
